Contact this trialFirst, we need to learn more about you.
Probiotic
CBM588 + Nivolumab + Ipilimumab for Advanced Kidney Cancer
Recruiting1 awardPhase 1
Duarte, California
This trial is testing the safety and effectiveness of using a probiotic called CBM588 in combination with two antibodies, nivolumab and ipilimumab, to treat patients with advanced kidney cancer
Fill-in a few details and create your profileSave answers to your profile & unlock recommendations.
We will keep your details privateWe won't share unless you give us permission. By completing this form you agree to our privacy policy and terms of service
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.
By clicking start, you agree to our
terms of service